ask="7.00"
ask_size="100"
average_daily_volume="137811"
bid="5.65"
bid_size="100"
book_value="3.28"
change="+0.25"
change_from_200_day_moving_average="-3.09"
change_from_50_day_moving_average="1.17"
change_from_52_week_high="-10.95"
change_From_52_week_low="2.25"
change_in_percent="+3.85%"
close="6.75"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.54"
ebitda="-19.37M"
eps_estimate_current_year="-2.81"
eps_estimate_next_quarter="-0.90"
eps_estimate_next_year="-2.84"
ex_dividend_date="N/A"
float_shares="5820000"
high="6.90"
high_52_weeks="17.70"
last_trade_date="2/16/2017"
last_trade_price="6.75"
last_trade_size="375"
last_trade_time="4:00pm"
low="6.60"
low_52_weeks="4.50"
market_capitalization="52.76M"
moving_average_200_day="9.84"
moving_average_50_day="5.58"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.85"
open="6.60"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-31.43%"
percent_change_from_50_day_moving_average="+20.92%"
percent_change_from_52_week_high="-61.86%"
percent_change_from_52_week_low="+50.00%"
previous_close="6.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.98"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="2.30"
stock_exchange="NCM"
symbol="TRIL"
volume="199933"
weeks_range_52="4.50 - 17.70"
